Exercise Program in Women With Metabolic Syndrome
2 novembre 2017 mis à jour par: Vera Novak, Beth Israel Deaconess Medical Center
The Effect of Mixed Aerobic and Strength Training Program on Physical Fitness and Cerebrovascular Function in Older Women With Metabolic Syndrome: A Pilot Study With Randomized Control Trial (RCT) Design
The purpose of this study is to test whether a supervised mixed aerobic and strength training (MAST) program is effective in improving overall physical fitness and blood flow in the brain and lowering risk factors of coronary artery disease (CAD) in women with metabolic syndrome.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
Metabolic syndrome is a cluster of conditions and disorders that increase the risk for coronary artery disease (CAD) and strokes.
Sedentary lifestyle is one of the risk factors, which decrease overall physical fitness and together with aging may lead to decrease in physical functioning in everyday life as well as changes in blood flow in the brain and cognitive functions.
Regular physical activity is associated with a reduced risk of cardiovascular disease.
It may also improve blood flow velocity and cognitive functions.
Physical activity should be as effective as possible, but also as safe as possible.
Supervised mixed aerobic and strength training (MAST) program for 4 months enables to individualize the intensity of aerobic exercise based on measured maximal exercise capacity.
Throughout each training session heart rate will be monitored with a new real time wireless ECG system.
Type d'étude
Interventionnel
Inscription (Réel)
28
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Massachusetts
-
Boston, Massachusetts, États-Unis, 02215
- Beth Israel Deaconess Medical Center, Harvard University
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
50 ans et plus (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Femelle
La description
Inclusion Criteria:
- Post-menopausal women
- Age 50 or over
- Diagnosed metabolic syndrome
Exclusion Criteria:
- Any unstable or acute medical condition that the study physician deem unsafe for participation
- Positive stress test for CAD or other ischemic conditions
- Myocardial infarction or major surgery within 6 months
- History of a clinically documented stroke
- Clinical dementia (by history) or inability to follow details of the protocol
- Carotid stenosis > 50% by medical history
- Insulin dependent diabetes mellitus (also type II, if using insulin) or history of severe hypoglycemic episodes within 6 months requiring hospitalization
- Liver or renal failure or transplant
- Severe blood pressure elevation (systolic BP > 180 and/or diastolic BP > 110 mm Hg)
- Anemia (Hb < 10)
- Seizure disorders
- Current recreational drug or alcohol abuse
- BMI > 45, but body weight under 280 lbs
- Inability to obtain permission for participation from the primary care physician
- Clinically significant and movement limiting hip, knee and/or back disorders or injury, and rheumatoid arthritis
- Transcranial Doppler (TCD) exclusion criteria - poor insonation window and TCD signal
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: MAST program
Mixed Aerobic and Strength Training program (MAST): Each exercise session consisted of 10 minutes of warm-up, 15-30 minutes of interval aerobic training by cycle ergometer according to the program, 20 minutes of strength training exercises, and 10 minutes of cool-down by stretching.
|
MAST program: twice a week for 4 months
|
|
Aucune intervention: UC
Usual Care (UC) with Educational Lectures: No exercise sessions.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Maximal Oxygen Uptake
Délai: At baseline and after 4 months of intervention
|
To obtain peak oxygen uptake (VO2max; ml-1/min-1/kg), a symptom-limited exercise stress test was performed on a cycle ergometer.
The test was preceded by a 2-minute warm-up at the intensity of 20 W. The first test load was 20 W, and was increased by 20 W at each 2-minute stage until the participants could no longer continue, i.e., they were unable to maintain pedaling frequency > 40 rpm, they achieved a respiratory exchange ratio of more than 1.0, or clinical criteria for test termination was observed.
VO2max was measured and monitored with a breath-by-breath gas exchange system.
|
At baseline and after 4 months of intervention
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Cerebral Blood Flow Velocity (BFV)
Délai: At baseline and after 4 months of intervention
|
Cerebral BFV was monitored using Transcranial Doppler Ultrasound.11
The middle cerebral artery was insonated from the temporal window by placing the 2-MegaHertZ (MHz) probe against the skin of the temporal region above the zygomatic arch.
The probe was positioned to obtain maximal BFV and was fixed at the desired angle using a 3-dimensional positioning system.
Once instrumented, BFV was continuously recorded throughout ten minutes of supine rest and 10-minutes on a table tilted to 80° from the horizontal position (head-up with foot plate support).
|
At baseline and after 4 months of intervention
|
|
Trail Making Test
Délai: At baseline and after 4 months of intervention
|
The Trail Making (TM) test is a measure of shifting attention.
Participants are required to sequentially connect a series of numbered circles (Part A), and then to alternate between numbers and letters sequentially (Part B) (e.g., A-1-B-2-C-3..).
Any participant who has not completed Part B within the standard 5 minutes (300 seconds) allotted for the task will be considered unable to complete the task.
The scores in Part A (TM-A), Part B (TM-B) T scores ( age, education adjusted), and their difference (TM-B -TM-A) were calculated and used to measure executive function, i.e., lower scores indicates better performance.
|
At baseline and after 4 months of intervention
|
|
Muscle Strength
Délai: At baseline and after 4 months of intervention
|
MAST sessions were held twice a week for 16 weeks.
Each exercise session consisted of 10 min of warm-up, 15-30 min of interval aerobic training by cycle ergometer according to the program, 20 min of strength training exercises, and 10 min of cool-down by stretching.
The target heart rate (HR) increased progressively from 50% up to 80% of HR reserve by the end of the intervention period.The Karvonen formula ([(HRmax - HRrest)×(0.50 to 0.80)] + HRrest) was used to calculate the target HR.
During every training session a new wireless computerized ECG monitoring system was used.
After aerobic training, the strength training program was performed.
Exercises used body mass as resistance and included squat, step-up-squat, step-up, heel rise, and sit-ups.
Dumbbells were used as extra weight (5 or 10% of body weight) during other exercises except for sit-ups.
The control group participated in an educational session once a month and kept physical activity diaries during the intervention period.
|
At baseline and after 4 months of intervention
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Les enquêteurs
- Chercheur principal: Vera Novak, MD, PhD, Beth Israel Deaconess Medical Center
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude
1 juillet 2009
Achèvement primaire (Réel)
1 mai 2010
Achèvement de l'étude (Réel)
1 décembre 2013
Dates d'inscription aux études
Première soumission
26 juin 2009
Première soumission répondant aux critères de contrôle qualité
26 juin 2009
Première publication (Estimation)
29 juin 2009
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
13 novembre 2017
Dernière mise à jour soumise répondant aux critères de contrôle qualité
2 novembre 2017
Dernière vérification
1 novembre 2017
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2009P000121
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .